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Abstract
A sensitive, reproducible reverse-phased high performance liquid chromatography electrospray tandem mass spectrometry (HPLC-
ESI-MS/MS) method with simple sample preparation was developed for the simultaneous determination of a wide range of ceramides, 
diacylglycerols (DAGs) in cultured cells. Chromatographic separation of the compounds was achieved in a 14-minute run using a 
C8 column with a gradient elution by methanol and 10 mM ammonium acetate buffer as mobile phase at a flow rate of 0.5 ml/min. 
Various ceramides, DAGs were detected with a triple quadrupol system in multiple reaction monitoring mode, which is based on a 
soft positive electrospray ionization. The usual sample preparation process was shortened by the application of pure methanol for the 
extraction instead of the widely used methanol/chloroform mixture. C17:0 ceramide which does not occur in the cell samples, was used 
as an internal standard. The sample preparation process was optimized and the methodology was tested on a human hepatocarcinoma 
cell culture. Our results clearly showed accumulation of some ceramides and DAGs in the cells treated with BSA-conjugated palmitate for 
8 hours. Since both ceramides and DAGs are important lipid intermediates and signal messengers, alteration in their cellular levels have 
major impact on cell functions, and thus our novel analytic method can be widely used in lipotoxicity research. The presented technique 
can be further developed to measure other intermediates of ceramide synthesis and other derivatives of DAGs as well.
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1 Introduction
Depot fat stored in the adipocytes contains fatty acids (FAs) 
ingested with animal fat [1] and with natural or hydrogenated 
plant oils [2, 3] as well as FAs synthesized endogenously in 
the fed state. As obesity and related diseases, such as car-
diovascular diseases, insulin resistance and nonalcoholic 
fatty liver disease have become epidemic, there is a strong 
emphasis on investigating their pathology. Adipocyte hyper-
trophy is an indispensable component of obesity in adults, 
and it often leads to a local inflammation in the overgrown 
adipose tissue, which in turn enhances triglyceride turnover 
and elevates serum free fatty acid (FFA) levels [4].
Oversupply of FFAs stimulates both lipid biosynthesis 
and FA degradation. Deleterious effects of excessive FFAs 
were mainly attributed to ectopic fat deposition in various 
cells, such as hepatocytes [4]. However, growing evidence 
shows that lipotoxic oxidative and endoplasmic reticulum 
(ER) stress [5], inflammation and apoptosis are mostly due 
to fatty acyl coenzyme A (acyl-CoA) build-up and to the 
consequent accumulation of certain lipid intermediates in 
the cells. Ceramides, which are amides of a sphingosine and 
a FA chain, constitute the hydrophobic backbone of a wide 
array of sphingolipids, play an important role in signaling. 
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They influence cell growth and proliferation [6] and cellular 
senescence [7], and cell death as they can induce apoptosis 
[8, 9]. Recently, many publications have also suggested the 
role of ceramides in the development of insulin resistance and 
in β-cell failure, and thus their importance in type 2 diabetes 
[10]. Intracellular ceramide production (Fig. 1) is potentially 
affected by fatty acyl-CoA supply at different acylations in 
the cell. De novo synthesis of ceramides starts with the con-
densation of palmitoyl-CoA and serine to 3-dehydrosphin-
ganine, and its subsequent reduction. The product, sphin-
ganine is N-acylated with another acyl-CoA by ceramide 
synthase. Sphingosine, an intermediate of sphingolipid deg-
radation can be recycled through N-acylation by sphingosine 
acyltransferases which can use various fatty acyl-CoA spe-
cies for substrates. Diacylglycerols (DAGs) are also import-
ant lipid species with signaling functions. These compounds 
have two fatty acyl groups in ester bonds with two hydroxyl 
groups of glycerol. As it is presented in Fig. 2, they can 
serve as precursors in the synthesis of triacylglycerols and 
complex glycerophospholipids such as phosphatidylserine 
(PS), phosphatidylethanolamine (PE), phosphatidylcholine 
(PC), phosphatidylinositol (PI), etc. or galactolipids such as 
monogalactosyldiacylglycerol (MGDG). When 1,2-DAGs 
are formed by the hydrolytic cleavage of plasma membrane 
glycerophospholipids, mostly phosphatidylinositols by phos-
pholipase C, they serve as signal messengers through the 
activation of protein kinase C isoenzymes [11]. DAGs also 
have an effect on insulin secretion in case of oversupply of 
FAs [12]. Since DAGs are central intermediates of phospho-
lipid metabolism, any alteration in their structure would 
largely affect the composition of cellular membranes as well.
It has become evident that FA surplus exerts many 
of its pathologically relevant deleterious effects in the 
cells through the accumulation of ceramides and DAGs. 
Therefore, biological and medical investigations on lipo-
toxicity, could growingly exploit the accurate and sensi-
tive analytical methods which are suitable for a simultane-
ous assessment of these two groups of lipid species.
Ceramides can be measured by different techniques, such 
as enzymatic measurements involving diacyglycerol kinase 
assay [13, 14], or chromatographic methods, such as thin-
layer chromatography [15, 16] or high-performance liquid 
chromatography [17-19]. However, these methods may have 
limitations regarding the quantification of individual cera-
mide species. Tandem mass spectrometry can be a useful 
method to quantify different forms of ceramide simultane-
ously. In case of multiple reaction monitoring mode, a prior 
separation step is not essential as the different transitions are 
specific to the molecules [20-23]. However, if tandem mass 
spectrometry is coupled to high-performance liquid chro-
matography, the selectivity improves and the method is more 
robust since the components are separated from the impu-
rities. An HPLC-MS/MS method was developed and used 
to quantify various ceramides in biological samples [23-26].
Fig. 1 De novo synthesis and salvage of ceramides. SPT: serine 
palmitoyl transferase, KDSR: 3-ketodihydrosphingosine reductase, 
CerS: ceramide synthases, DES: dihydroceramide desaturase.
Fig. 2 Metabolism of diacylglycerols. CDS: cytidinediphosphate-
diacylglycerol synthase, CEPT: choline/ethanolamine 
phosphotransferase, CPT: choline phosphotransferase, DGK: 
diacylglycerol kinase, PPH: phosphatidate phosphohydrolase PI 
PLC: phosphoinositide-phospholipase C, MGAT: monoacylglycerol 
acyltransferase, DGAT: diacylglycerol acyltransferase, DGL: 
diacylglycerol lipase, TGL: triacylglycerol lipase, MGD: 
monogalactosyl-diacyclglycerol synthase.
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Measurement of DAGs was carried out by DAG kinase 
assay [12], capillary gas chromatography [27] and liquid 
chromatography coupled to mass spectrometry [28-30]. 
Leiker et al. used the 2,4-difluorophenyl urethane deriv-
atives of DAGs in a normal phase separation [28] to sepa-
rate 1,2-diacylglycerols and 1,3-diacylglycerols.
The main problem to be faced in case of mass spectrom-
etry is the poor ionization ability of DAGs. To avoid this 
problem, derivatizing compounds, such as N-chlorobetainyl 
chloride [30] are used in the sample preparation step, alter-
natively ammonium acetate [28] or sodium acetate [29] buf-
fers are added to the eluent.
We sought to develop a sensitive and reproducible 
HPLC-MS/MS method with a simple, chloroform-free 
sample preparation which is suitable for the quantitation 
of ceramides and DAGs in a single run. Here we demon-
strate a 14-min run to separate 12 individual lipid inter-
mediates. Our method permits the use of pure methanol as 
an extracting agent instead of a chloroform/methanol mix-
ture. This method was tested analyzing the effects of pal-
mitate treatment on ceramide and DAG levels in HepG2 
human hepatocarcinoma cells.
2 Materials and methods
2.1 Chemicals and reagents
C16:0, C17:0, C18:0, C18:1(9Z) (>99 %) ceramides were 
purchased from Avanti Polar Lipids Inc., 1,2-dipalmi-
toyl-rac-glycerol (>99 %), 1-palmitoyl-2-oleoyl-sn-glyc-
erol (>99 %), 1,2-dioleoyl-snglycerol (>97 %), 1-octade-
canoyl-2hexandecanoylsnglycerol (>99 %), palmitic acid 
(>99 %), ammonium acetate (>98 %) and bovine serum 
albumin (BSA) were from Sigma-Aldrich (St. Louis, MO). 
Methanol (gradient grade) and acetonitrile (gradient grade) 
were obtained from Merck. Chloroform (99.8 %) for lipid 
extraction was from Panreac and isopropanol was purchased 
from Molar Chemicals. All experiments and measurements 
were carried out by using Millipore ultrapure water.
2.2 Standard solutions
Standard stock solutions of C16:0, C18:0 and C18:1 cera-
mides and all DAG standards were prepared in methanol 
in a concentration of 5 µg/ml each. C17:0 ceramide was 
used as an internal standard in a concentration of 50 ng/ml. 
The solutions were kept in glass vials at 20 °C.
2.3 Cell cultures
HepG2 human hepatocarcinoma cells were purchased from 
Sigma-Aldrich (St. Louis, MO) (cat. number: 85011430-
1VL) and cultured in Minimum Essential Medium Eagle 
containing Earle's Salts and sodium bicarbonate, supple-
mented with 2 mM L-glutamine, 1 % non-essential amino 
acids, 10 % FBS and 1 % antibiotics (Thermo Scientific), 
at 37 °C in humidified atmosphere, containing 5 % CO2.
2.4 Cell treatment with fatty acids
Treatment of the cells with albumin-conjugated palmi-
tate was based on our previous studies [31]. Briefly, before 
treatment, the culture medium was changed for FBS and 
antibiotic free medium for 1 hour. Palmitate was diluted in 
isopropanol to a concentration of 50 mM, conjugated with 
4.16 mM FA free BSA in 1:4 ratios, on 37 °C for 1 hour. 
The working solution was always freshly prepared with 
FBS free and antibiotic free medium, and it contained pal-
mitic acid at a final concentration of 250 µM. Cells were 
treated for 8 hours at 70-80 % confluence in 6-well plates.
2.5 Sample preparation–Extraction
At 70-80 % confluence, cells were washed once with 
phosphate buffer (PBS), then harvested in 200 µl PBS by 
scraping. The samples were then centrifuged in a bench-
top centrifuge (10 min, 1000 rpm, 4 °C). The supernatant 
was removed, and the cells were suspended in 115 µl PBS. 
15 µl of each cell suspension was removed for determina-
tion of protein concentration, and the rest was centrifuged 
(10 min, 1000 rpm, 4 °C). The supernatant was removed 
and the remaining sample was suspended in 200 µl of 
isopropanol/methanol (50/50 v/v%), which already con-
tained the C17:0 ceramide (50 ng/ml). After this procedure, 
the samples were immediately frozen at 20 °C and stored 
at 20 °C until further processing.
Before the analysis, the samples were thawed at room 
temperature. The samples were sonicated for 15-20 sec using 
an ultrasonic sonotrode, then centrifuged in a benchtop cen-
trifuge (10 min, 13400 rpm, 24 °C). The supernatants were 
transferred to vials for immediate liquid chromatography 
tandem mass spectrometry analysis.
2.6 Measurement of protein concentration
Cells were washed twice with PBS, then harvested in 
100 µl lysis buffer by scraping. The lysis buffer contained 
0.1 % SDS, 5 mM EDTA, 150 mM NaCl, 50 mM Tris, 
1 % Tween 20, 1 mM Na3VO4, 1 mM PMSF, 10 mM benz-
amidine, 20 mM NaF, 1 mM pNPP and protease inhibitor 
cocktail. The lysates were centrifuged with benchtop cen-
trifuge (10 min, 10000 rpm, 4 °C). Protein concentration 
of the supernatant was measured with Pierce BCA Protein 
Kit Assay (Thermo Scientific) according to the manufac-
turer’s recommendation, then stored at 20 °C until use.
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2.7 Chromatographic separation
Compounds were separated by high performance liquid 
chromatography using a Perkin Elmer series 200 high 
pressure gradient pump, autosampler, online degasser and 
a thermostat. A Kinetex® 5 µm, C8 100 Å, LC Column, 
100 x 3 mm column was used at 0.5 ml/min flow rate with 
a gradient elution of methanol (mobile phase A) and 10 mM 
ammonium-acetate (mobile phase B): 0 min at 90 % A; 
1 min at 90 % A; 9 min at 95 % A; 10.5 min at 98 % A; 
11.5 min at 98 % A; 12 min at 90 % A; 14 min at 90 % A.
2.8 Mass spectrometry
Ceramide and DAG compounds were detected using a tri-
ple quadrupole mass spectrometer (Applied Biosystems 
MDS SCIEX 4000 Q TRAP). 
The instrument was used in positive multiple reaction 
monitoring mode. The source parameters of the mass spec-
trometer are presented in Table 1. The transitions and reten-
tion times for each ceramide and DAG are shown in Table 2.
2.9 Quantification of ceramide and diacylglycerol levels
Ceramides and DAGs were quantified by the ratios of their 
peak areas and of the C17:0 ceramide. This compound is 
a non-naturally occurring ceramide, thus it can be used as 
an internal standard.
3 Results
3.1 Optimization of tandem mass spectrometry
Full scan mass spectra were recorded for each ceramide 
and DAG standard in positive ion mode during direct infu-
sion. Ceramides gave protonated ion spectrum, however, 
DAGs showed poor ionization. Thus, we added ammo-
nium-acetate in a concentration of 10 mM to the eluent. 
This way, the ammonium-adduct of the DAGs became 
the precursor ion for this compound. Each precursor ion 
was separated in the first quadrupole (Q1), fragmented in 
the second quadrupole (Q2), and the product ions were 
scanned in the third quadrupole (Q3). We found that, as 
reported before [20, 22, 25, 32], one typical fragment for 
ceramides is the m/z 264. This is generated with the loss 
of the acyl group and two molecules of water. (Fig. 3). 
The other chosen transition was produced with the loss of 
one molecule of water from the precursor ion.
Fatty acid synthase enzyme yields palmitic acid (16:0) 
as the major primary intermediate of de novo FA syn-
thesis in human cells. Palmitic acid can be elongated by 
two-carbon units and/or desaturated by enzyme systems 
in the ER membrane, thus it serves as the precursor of all 
other endogenous FAs. We aimed to determine the levels 
of those DAGs that contain the most abundant endogenous 
FAs of human cells, such as palmitic (16:0), stearic (18:0), 
palmitoleic (16:1 cis Δ9) and oleic (18:1 cis Δ9) acids in var-
ious combinations. In case of DAGs, we decided to use the 
ammonium-adduct as a precursor ion for each DAG, and 
the two daughter ions were generated with the loss of the 
ammonia and one of the FA chain (Fig. 4). For those DAGs, 
which contained two identical FAs, the other daughter ion 
was produced from the precursor ion with the loss of the 
ammonia and one molecule of water. Among the biolog-
ically relevant DAGs having two identical FA chains, the 
Table 1 Source parameters of mass spectrometer
Global source settings
Collision gas (CAD) Medium
Curtain gas (CUR) 30 psi
Nebulizer gas (GSI) 30 psi
Auxiliary gas (GS2) 20 psi
Ion spray voltage (IS) 5500 V
Temperature (TEM) 400 °C
Entrance potential (EP) 10 V
Table 2 Quantitative LC/MS/MS parameters for ceramide and 
diacylglycerol analysis
Compound Symbol Mass transition (m/z)
Retention 
time (min)
N-palmitoyl-
sphingosine C16:0
538.60–264.30
7.2
538.60–520.60
N-heptadecanoyl-
sphingosine C17:0
552.61–264.30
8.0
552.61–534.60
N-stearoyl-sphingosine C18:0
566.52–264.30
8.8
566.52–548.60
N-oleoyl-sphingosine C18:1
564.66–264.30
6.5
564.66–546.50
Dipalmitoyl-glycerol 16:0-16:0
586.50–313.30
10.2
586.50–551.50
Palmitoyl-palmitoleoyl-
glycerol 16:0-16:1
584.50–311.30
9.1
584.50–313.30
Palmitoyl-stearoyl-
glycerol 16:0-18:0
614.60–313.30
11.7
614.60–341.30
Palmitoyl-oleoyl-
glycerol 16:0-18:1
612.50–313.30
10.7
612.50–339.30
Palmitoleoyl-oleoyl-
glycerol 16:1-18:1
610.50–311.30
9.9
610.50–339.30
Distearoyl-glycerol 18:0-18:0
642.60–341.30
12.9
642.60–607.60
Stearoyl-oleoyl-
glycerol 18:0-18:1
640.60–339.30
12.0
640.60–341.30
Dioleoyl-glycerol 18:1-18:1 638.80–339.30 11.4
Somogyi et al.
Period. Polytech. Chem. Eng., 64(4), pp. 421–429, 2020 |425
second transition of only dioleoyl-glycerol (18:118:1) can-
not be used because it yields ions of the same m/z as the 
ones produced from the 18:018:2 DAG, so in this case, 
only one transition, the 638.6 → 339.3 was used.
3.2 Liquid chromatography
Fig. 5 shows a typical chromatogram of ceramides and 
DAGs of a control sample of the cell culture. Although in 
some cases, there is no baseline separation between the 
investigated compounds, with the MRM mode we can per-
form the specific identification of coeluting ceramides and 
DAGs. By using this gradient method, we were able to sep-
arate four ceramides and eight DAGs during a 14 min run.
3.3 Sample preparation
A chloroform/methanol (1:2 v/v) mixture is often used 
for the extraction of ceramides. However, the loss during 
sample drying is intolerable when studying cultured cells, 
due to very small amount of the samples, and carcinogenic 
properties of chloroform are well-known, and hence, we 
decided to use chloroform-free methanol for extraction. 
Therefore, we studied the difference between the follow-
ing two extraction methods using either pure methanol or 
a chloroform/methanol mixture. For extraction with meth-
anol only, washed cells were suspended in methanol, soni-
cated for 15-20 sec, and then centrifuged at 13400 rpm for 
10 minutes. The supernatant was directly injected from 
HPLC vials. For extraction with a chloroform/methanol 
mixture, 45 µl of chloroform was added to 90 µl of cell 
suspension in methanol. The samples were sonicated and 
centrifuged as above. The supernatant was then dried and 
reconstituted in 90 µl of methanol. The solutions were son-
icated for 15-20 sec and centrifuged again, and the super-
natants were transferred to HPLC vials for measurement. 
We found no difference between the results obtained with 
two methods (Fig. 6); therefore, to save time and samples, 
ceramides and DAGs were extracted with methanol only 
in the subsequent measurements.
Two different approaches were used to normalize the 
measured amount of ceramides and DAGs. One was based 
on the measurement of wet cell mass, i.e. all of the super-
natant was removed from the washed cell pellets, and the 
volume of methanol in which the cells were suspended was 
proportional to the pellets' weight. The other approach was 
based on the measurement of protein content, i.e. 15 µl of 
each cell suspension in PBS was withdrawn before pellet-
ing the cells to determine the protein concentration, and the 
amount of methanol for suspension of the pellet was con-
stant. The lipid concentrations were normalized to the pro-
tein concentration of the same sample. Since the first method 
did not yield precise and reliable results, all data were nor-
malized to protein contents in the subsequent experiments.
Fig. 3 Typical fragment ion of m/z = 264 of ceramides generated upon 
positive ESI ionization
Fig. 4 Fragmentation of diacylglycerols with the loss of one fatty 
acid chain
Fig. 5 Typical chromatograms of a control cell sample containing the 
measured ceramides and diacylglycerols. With the MRM mode, the 
specific identification of coeluting compounds can be achieved
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The percentage of ceramide and DAG recovery was 
measured by adding known amount of ceramides and 
DAGs to pooled cell suspension. Recovery was between 
79.1 % and 86.4 %.
3.4 Effect of palmitate treatment on ceramide and 
DAG levels in HepG2 cells
After optimizing the sample preparation steps, we treated 
the cells with BSA-conjugated palmitate at a concentra-
tion of 250 µM for 8 hours, and prepared samples from the 
collected cells as described.
Our results show an obvious accumulation of several pal-
mitate derivatives. We observed an approximately 5-fold 
elevation in the level of C16:0 ceramide (0.192 ± 0.026 vs 
0.976 ± 0.232 µg/mg protein in control vs palmitate-treated, 
respectively) and a 5.5-fold elevation in the level of C18:0 
ceramide (0.0153 ± 0.004 vs 0.086 ± 0.015 µg/mg protein in 
control vs palmitate-treated, respectively) (Fig. 7). The C18:0 
ceramide contains a stearoyl chain, which is produced in the 
cells by the elongation of palmitate.
A significant elevation was found in the amount of differ-
ent DAGs as well (Fig. 8), especially in the dipalmitoyl-glyc-
erol (16:0-16:0) (18.5-fold, 0.71 ± 0.233 vs 13.08 ± 2.914 µg/
mg protein in control vs palmitate-treated, respectively) 
the palmitoyl-palmitoleoyl-glycerol (16:0-16:1) (8-fold, 
0.36 ± 0.059 vs 2.96 ± 0.389 µg/mg protein in control and 
palmitate-treated, respectively) and palmitoyl-stearoyl-glyc-
erol (16:0-18:0) (6.5-fold, 0.12 ± 0.054 vs 0.77 ± 0.214 µg/mg 
protein in control vs palmitate-treated, respectively) levels.
The ratio of fully saturated DAGs (i.e. containing satu-
rated FAs only) and partly or fully unsaturated ones (i.e. hav-
ing at least one unsaturated FA chain) changed remarkably, 
from 0.11 to 0.82 upon palmitate treatment (Fig. 9).
4 Discussion
The role of ceramides and DAGs in a variety of pathologi-
cal conditions has attracted a growing attention in the last 
few years. Excessive FA supply, which occurs in high-fat 
diet and in obesity, causes an elevation of intracellular acyl-
CoA levels and thus stimulates several acylation reactions 
involved in the biosynthesis of complex lipids. Acceleration 
of sphingosine N-acylation produces ceramides, which are 
known to trigger ER stress, insulin resistance and apopto-
sis in various cell lines. Enhanced acylations also lead to 
Fig. 6 Comparison of the different extraction methods. MeOH: Washed 
cells were suspended in methanol, sonicated for 15-20 sec, and then 
centrifuged at 13400 rpm for 10 minutes. The supernatant was directly 
injected from HPLC vials. MeOH/chloroform: 45 µl chloroform was 
added to 90 µl cell suspension in methanol. The samples were sonicated 
and centrifuged as above. The supernatant was then dried, reconstituted 
in 90 µl methanol, sonicated, centrifuged, and the supernatants were 
transferred to vials for HPLC analysis. Relative ceramide (A) and 
DAG (B) peak areas compared to the internal standard peak area are 
presented as mean values ± S.D.; n=10.
Fig. 7 Effect of palmitate treatment on ceramide levels. Cells were treated 
with BSA (control) or BSA-conjugated palmitate (250 µM) at 70-80 % 
confluence for 8 h. Ceramide levels were measured by LC-MS/MS and 
normalized to 1 mg protein. Data are shown as means ± S.D.; n=10.
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the production of triglycerides, and deposition of fat drop-
lets is an obvious sign of lipotoxicity. It has been revealed, 
however, that obstruction of triglyceride synthesis before 
the final step, and the consequent accumulation of DAGs is 
especially deleterious because it activates different members 
of the protein kinase C (PKC) family, and hence contrib-
utes to stress and insulin resistance. Therefore, an increas-
ing number of cellular and in vivo studies aim to monitor the 
intracellular levels of ceramides and DAGs along with alter-
ations in cellular functions and development of characteris-
tic pathological conditions.
Its high selectivity, sensitivity and accuracy make 
HPLC-ESI-MS/MS technique suitable for efficient and 
precise quantitative analysis of various cellular compounds 
of low molecular weight and of similar structures in biolog-
ical matrices [33]. Here, we demonstrate the development 
of a reverse-phased HPLC-ESI-MS/MS method for the 
simultaneous determination of a wide range of ceramides 
and DAGs in cultured cells. A non-physiological C17:0 
ceramide containing a fatty acyl chain of odd number of 
carbons, which cannot be produced in mammalian cells, 
was used as an internal standard in our methodology. 
The lipid species were separated from the impurities by 
liquid chromatography, and multiple reaction monitoring 
mode enabled the identification of coeluting components. 
Regarding the sample preparation, most of the experiments 
refer to the method reported by Bligh and Dyer [34] which 
uses a chloroform-methanol mixture to extract and purify 
lipids from biological samples. However, we demonstrate 
here, that the use of methanol alone provides the same yield 
in one step without a time-consuming extraction protocol 
in case of ceramides and DAGs.
Our experiments on palmitate-treated cultured cells 
clearly show the accumulation of lipid-intermediates. 
In case of ceramides, the increasing levels have two expla-
nations. On one hand, the oversupply of palmitoyl-CoA 
induces the synthesis of sphinganine, which can react 
with another acyl-CoA in the acylation catalyzed by the 
ceramide synthase. Elongation of a palmitoyl-CoA yields 
stearoyl-CoA, which can give rise to the C18:0 ceramide. 
On the other hand, acylation of sphingosine, an interme-
diate of sphingolipid breakdown also produces ceramides 
in the salvage pathway. Manukyan et al. [35] used two dif-
ferent enzyme inhibitors, a serine palmitoyl transferase 
and a ceramide synthase inhibitor, to determine whether it 
is the de novo synthesis or the salvage pathway that plays 
the primary role in the accumulation of ceramides during 
prolonged exposure to FAs. Their results suggest that the 
de novo synthesis and the salvage pathway contributes 
equally to the increased ceramide levels.
In case of DAGs in palmitate treated cells, we found 
significantly elevated levels of all examined DAGs except 
the palmitoleoyl-oleoyl-glycerol and dioleoyl-glycerol. 
Interestingly, we observed a 17-fold elevation in the total 
level of DAGs containing two saturated fatty acyl chains. 
The synthesis of triglycerides follows a genetically deter-
mined pattern. Normally, a saturated fatty acyl group 
occupies the first position of glycerol and an unsaturated 
fatty acyl group is attached in the second position [36]. 
This may suggest that the further acylation of the fully 
saturated DAGs may stall. Moreover, since DAGs are pre-
cursors of phospholipids, their structure has direct effects 
on the composition of the membrane lipids. The increased 
level of saturation of membrane lipids has been reported 
to trigger the ER stress [4, 5], which in turn may cause 
cell death, fibrosis and inflammation.
Fig. 8 Effect of palmitate treatment on diacylglycerol levels. Cells were 
treated with BSA (control) or BSA-conjugated palmitate (250 µM) at 
70-80 % confluence for 8 h. Diacylglycerol levels were measured by LC-
MS/MS normalized to 1 mg protein. Data are mean values ± S.D.; n=10.
Fig. 9 Alteration in the ratio of fully saturated and at least partly 
unsaturated diacylglycerols upon palmitate treatment. Cells were treated 
with BSA (control) or BSA-conjugated palmitate (250 µM) at 70-80 % 
confluence for 8 h. The amounts of saturated (16:016:0, 16:018:0, 18:0-
18:0) and at least partly unsaturated (16:016:1, 16:018:1, 16:118:1, 18:018:1, 
18:118:1, 16:1-18:1) DAGs were measured by LC-MS/MS.
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